OpenVSafe by OpenVAERS
Search V-safe

BM3-22539-67727

3 vaccinations 32 coded responses 40 check-ins 31 free-text entries 1 call case
Sex
Female
Age at first dose
56-60
ZIP prefix
554 / MN
Registered
2021-06-11
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
1464088 (opens in a new window) high 10 / 11 — 2 of 6 VAERS symptoms same dose (2) MN matches 2021-07-02 / 2021-07-03 / 2021-07-12
received the same day as the last call
case 833123

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-06-11
    Registered in v-safe
  2. 2021-06-11
    Dose 1 — Pfizer-BioNTech
  3. 2021-06-11
    Survey response — day 0, dose 1
    MedDRA: Dry mouth, Vision blurred — Feeling: Fair · Site: Pain · Headache · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Extreme dry mouth and blurriness in my eyes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-06-12
    Survey response — days 1–6 daily, dose 1
    MedDRA: Musculoskeletal stiffness, Vision blurred — Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Abdominal pain · Be unable to do your normal daily activities
    Free text: Stiff neck. Eye blurriness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-06-13
    Survey response — days 1–6 daily, dose 1
    MedDRA: Vision blurred — Feeling: Good · Site: Pain, Swelling, Itching · Muscle or body aches · Be unable to do your normal daily activities
    Free text: Blurriness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-06-14
    Survey response — days 1–6 daily, dose 1
    MedDRA: Vision blurred — Feeling: Good
    Free text: Blurriness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-06-15
    Survey response — days 1–6 daily, dose 1
    MedDRA: Vision blurred — Feeling: Good
    Free text: Blurriness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-06-16
    Survey response — days 1–6 daily, dose 1
    MedDRA: Vision blurred — Feeling: Good
    Free text: Blurriness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-06-17
    Survey response — days 1–6 daily, dose 1
    MedDRA: Fatigue, Vision blurred — Feeling: Good
    Free text: Blurriness and very tired
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-06-18
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-06-26
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-07-02
    Dose 2 — Pfizer-BioNTech
  13. 2021-07-02
    Survey response — day 0, dose 2
    MedDRA: Vision blurred — Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Eye blurriness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-07-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: Vision blurred — Feeling: Poor · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Free text: Eye blurriness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-07-04
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site bruising, Injection site hypoaesthesia, Vision blurred — Feeling: Poor · Site: Pain, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Blurriness and numbness at injections site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-07-05
    Survey response — days 1–6 daily, dose 2
    MedDRA: Vision blurred — Feeling: Fair · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Blurriness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-07-06
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site hypoaesthesia, Musculoskeletal stiffness, Vision blurred — Feeling: Fair · Site: Pain, Itching · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school
    Free text: Numbness at injection. Eye blurriness stiff neck
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-07-07
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cough, Oropharyngeal pain, Vision blurred — Feeling: Fair · Site: Pain · Headache, Muscle or body aches · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Sore throat cough blurriness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-07-07
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  20. 2021-07-08
    Survey response — days 1–6 daily, dose 2
    MedDRA: Oropharyngeal pain, Vision blurred — Feeling: Fair · Site: Pain · Muscle or body aches · Be unable to work or attend school
    Free text: Sore throat and blurriness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-07-09
    Health check-in — day 7, dose 2
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  22. 2021-07-12
  23. 2021-07-12
    Call successful
    Completed over the phone
  24. 2021-07-16
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-07-23
    Survey response — day 21, dose 2
    MedDRA: Candida infection, Ear disorder, Vision blurred — Feeling: Fair
    Free text: Eye blurriness issues ThrushEar issue
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  26. 2021-07-31
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-08-06
    Survey response — day 35, dose 2
    MedDRA: Cough, Headache, Vision blurred — Feeling: Fair
    Free text: Eye blurriness Headache Slight cough
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  28. 2021-08-13
    Survey response — day 42, dose 2
    MedDRA: Muscle spasms, Vision blurred — Feeling: Fair
    Free text: Eye blurriness Leg cramps
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  29. 2021-10-01
    Survey response — 3 months, dose 2
    MedDRA: Ear pain, Muscle spasms — Feeling: Good
    Free text: Intermittent earachesIntermittent muscle cramps
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-12-31
    Survey response — 6 months, dose 2
    MedDRA: Arthralgia — Feeling: Good
    Free text: Joint pain in hands
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-01-14
    Dose 3 — Pfizer-BioNTech
  32. 2022-01-14
    Survey response — day 0, dose 3
    MedDRA: Dizziness — Feeling: Fair · Site: Pain, Redness, Swelling · Chills, Fatigue or tiredness, Nausea · Be unable to work or attend school
    Free text: Lightheaded
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-01-15
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dizziness — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Free text: Light headed
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-01-16
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dizziness, Vision blurred — Feeling: Poor · Site: Pain, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school
    Free text: Light headed blurry vision
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-01-17
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dizziness, Vision blurred — Feeling: Fair · Site: Pain, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Nausea
    Free text: Blurriness and lightheaded
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-01-18
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dizziness, Vision blurred — Feeling: Fair · Site: Pain, Itching · Fever · Headache, Nausea, Diarrhea, Abdominal pain
    Free text: Vision blurriness and lightheaded
    MedDRA releases: 2024-11 · check-in free text available
  37. 2022-01-19
    Survey response — days 1–6 daily, dose 3
    MedDRA: Vision blurred — Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tiredness, Nausea, Diarrhea
    Free text: Blurriness
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-01-20
    Survey response — days 1–6 daily, dose 3
    MedDRA: Vision blurred — Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tiredness, Nausea, Diarrhea
    Free text: Blurriness
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-01-21
    Survey response — day 7, dose 3
    MedDRA: Vision blurred — Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tiredness, Diarrhea
    Free text: Blurriness
    MedDRA releases: 2024-11 · check-in free text available
  40. 2022-01-28
    Survey response — day 14, dose 3
    MedDRA: Diarrhoea, Lymphadenopathy, Office visit, Oropharyngeal pain, SARS-CoV-2 test negative, Vision blurred — Feeling: Fair · Be unable to work or attend school
    Free text: Very sore throat and swollen lymph nodes. Diarrhea and eye blurriness Dr said most likely immune system still fighting booster Negative covid test
    MedDRA releases: 2024-11 · check-in free text available
  41. 2022-02-05
    Survey response — day 21, dose 3
    MedDRA: Ear pain, Insomnia, Muscle spasms — Feeling: Fair
    Free text: Ear ache Hand cramps Insomnia
    MedDRA releases: 2024-11 · check-in free text available
  42. 2022-02-11
    Survey response — day 28, dose 3
    MedDRA: Diarrhoea, Headache, Pain in extremity — Feeling: Fair
    Free text: Leg pain diarrhea headaches
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-02-19
    Survey response — day 35, dose 3
    MedDRA: Dizziness, Headache, Vision blurred — Feeling: Fair
    Free text: Lightheadedness I blurriness headaches
    MedDRA releases: 2024-11 · check-in free text available
  44. 2022-02-25
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  45. 2022-04-15
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  46. 2022-07-16
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  47. 2023-01-14
    Survey response — 12 months, dose 3
    MedDRA: COVID-19, Nasopharyngitis, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-06-11Pfizer-BioNTech
22021-07-02Pfizer-BioNTech No
32022-01-14Pfizer-BioNTech No

Call center

1 call center case

1 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 9 — day 0, dose 1

2021-06-11

Systemic reaction (other): Extreme dry mouth and blurriness in my eyes

Release 9 — days 1–6 daily, dose 1

2021-06-12

Systemic reaction (other): Stiff neck. Eye blurriness

2021-06-13

Systemic reaction (other): Blurriness

2021-06-14

Systemic reaction (other): Blurriness

2021-06-15

Systemic reaction (other): Blurriness

2021-06-16

Systemic reaction (other): Blurriness

2021-06-17

Systemic reaction (other): Blurriness and very tired

Release 9 — day 0, dose 2

2021-07-02

Systemic reaction (other): Eye blurriness

Release 9 — days 1–6 daily, dose 2

2021-07-03

Systemic reaction (other): Eye blurriness

2021-07-04

Systemic reaction (other): Blurriness and numbness at injections site

2021-07-05

Systemic reaction (other): Blurriness

2021-07-06

Systemic reaction (other): Numbness at injection. Eye blurriness stiff neck

2021-07-07

Systemic reaction (other): Sore throat cough blurriness

2021-07-08

Systemic reaction (other): Sore throat and blurriness

Release 9 — day 21, dose 2

2021-07-23

Symptoms: Eye blurriness issues ThrushEar issue

Release 9 — day 35, dose 2

2021-08-06

Symptoms: Eye blurriness Headache Slight cough

Release 9 — day 42, dose 2

2021-08-13

Symptoms: Eye blurriness Leg cramps

Release 9 — 3 months, dose 2

2021-10-01

Symptoms: Intermittent earachesIntermittent muscle cramps

Release 10 — 6 months, dose 2

2021-12-31

Symptoms: Joint pain in hands

Release 10 — day 0, dose 3

2022-01-14

Systemic reaction (other): Lightheaded

Release 10 — days 1–6 daily, dose 3

2022-01-15

Systemic reaction (other): Light headed

2022-01-16

Systemic reaction (other): Light headed blurry vision

2022-01-17

Systemic reaction (other): Blurriness and lightheaded

2022-01-18

Systemic reaction (other): Vision blurriness and lightheaded

2022-01-19

Systemic reaction (other): Blurriness

2022-01-20

Systemic reaction (other): Blurriness

Release 11 — day 7, dose 3

2022-01-21

Systemic reaction (other): Blurriness

Release 11 — day 14, dose 3

2022-01-28

Symptoms: Very sore throat and swollen lymph nodes. Diarrhea and eye blurriness Dr said most likely immune system still fighting booster Negative covid test

Release 11 — day 21, dose 3

2022-02-05

Symptoms: Ear ache Hand cramps Insomnia

Release 11 — day 28, dose 3

2022-02-11

Symptoms: Leg pain diarrhea headaches

Release 11 — day 35, dose 3

2022-02-19

Symptoms: Lightheadedness I blurriness headaches

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia · · ✓
SDCandida infection ✓ · ✓
SDCough ✓ · ✓
SDCOVID-19 · · ✓
SDDiarrhoea · · ✓
SDDizziness · · ✓
SDEar disorder ✓ · ✓
SDEar pain · · ✓
SDHeadache ✓ · ✓
SDInsomnia · · ✓
SDLymphadenopathy · · ✓
SDMuscle spasms ✓ · ✓
SDNasopharyngitis · · ✓
SDOffice visit · · ✓
SDOropharyngeal pain · · ✓
SDPain in extremity · · ✓
SDSARS-CoV-2 test negative · · ✓
SDSARS-CoV-2 test positive · · ✓
SDVision blurred ✓ · ✓
SROCough ✓ ✓ ✓
SRODizziness · · ✓
SRODry mouth ✓ ✓ ✓
SROFatigue ✓ ✓ ✓
SROInjection site bruising ✓ ✓ ○
SROInjection site hypoaesthesia ✓ ✓ ✓
SROMusculoskeletal stiffness ✓ ✓ ✓
SROOropharyngeal pain ✓ ✓ ✓
SROVision blurred ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release